Long-term use of clopidogrel in patients with atherosclerotic vascular disease can effectively reduce the combined risk of ischemic stroke, myocardial infarction, or vascular death.
Long term administration of clopidogrel in patients with atherosclerotic vascular diseases can effectively reduce the combined risk of ischemic stroke, myocardial infarction or vascular death.
Long-term administration of clopidogrel in patients with atherosclerotic vascular diseases can effectively reduce the combined risk of ischemic stroke, myocardial infarction or vascular death.